Skip to main content

Anderson Robert A.'s Form 4 filing

bioAffinity Technologies, Inc. (BIAF) · filed Dec 2, 2022

Accession no.
0001493152-22-034379
Filed
Dec 2, 2022
Trade date
Aug 31, 2022
Filing delay
93 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 2 derivative transactions. It was filed 93 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Anderson Robert A.CIK 0001730173Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 31, 2022Common Stock, par value $0.007PPurchaseAcquired+4,081––4,081Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Aug 31, 2022Common StockPPurchaseAcquired+4,081––4,081Direct
Aug 31, 2022Common StockPPurchaseAcquired+4,081––4,081Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)